Revascularization by Peripheral Blood Mononuclear Cell Transplantation - Revascularization by Peripheral Blood Mononuclear Cell Transplantation

Kumamoto University0 sites6 target enrollmentOctober 17, 2017

Overview

Phase: 未知
Intervention: Not specified
Conditions: Critical limb ischemia due to peripheral artery disease (critical limb ischemia) and Buerger&#39
Sponsor: Kumamoto University
Enrollment: 6
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

October 17, 2017

End Date

March 31, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\) Patients who have severe hypersensitivity or history of side effects to aphaeresis. 2\) Patients who have malignant tumor or history of malignancy within the past 3 years. 3\) Patients who have experienced acute myocardial infarction, unstable angina pectoris, myocarditis or cerebral infarction within 3 months. 4\) Patients with active infection. 5\) Patients who are pregnant or might be pregnant. 6\) Patients with proliferative diabetic retinopathy (untreated, medium\-term and late proliferative retinopathy) the end of treatment example is excluded. 7\) Patients with platelets less than 70,000 platelets in blood test just before apheresies. 8\) Patients with less than serum albumin 2 mg/dL. 9\) Patients who are judged inappropriate for this trial by their attending physician.